Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome.

Background: Anemia is frequent in acute coronary syndrome (ACS) patients and is associated with worse clinical outcomes. We aimed to investigate the therapeutic strategies, the use of novel P2Y inhibitors, and the prognostic implication of anemia in a "real world" cohort of ACS patients.

Methods: This is an observational and prospective registry including 1717 ACS patients from three tertiary hospitals.